SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001011438-21-000156
Filing Date
2021-05-25
Accepted
2021-05-25 17:05:56
Documents
1
Group Members
ALEXANDER J. DENNER, PH.D.

Document Format Files

Seq Description Document Type Size
1 form_sc13da-sarissa.htm SC 13D/A 49999
  Complete submission text file 0001011438-21-000156.txt   51714
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Subject) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-80415 | Film No.: 21961593
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 660 STEAMBOAT ROAD GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

IRS No.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A